Common Equity: The sum of all common equity items.
Tango Therapeutics, Inc. (TNGX) had Common Equity of $346.18M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.00M |
|
$-38.75M |
|
-- |
|
$0.00M |
|
$41.86M |
|
$-41.86M |
|
$3.06M |
|
$-38.80M |
|
$-38.80M |
|
$-38.75M |
|
$-38.75M |
|
$-38.75M |
|
$-38.75M |
|
$-41.86M |
|
$-42.15M |
|
116.17M |
|
116.17M |
|
$-0.30 |
|
$-0.29 |
|
| Balance Sheet Financials | |
$353.76M |
|
$6.87M |
|
$44.93M |
|
$398.69M |
|
$21.68M |
|
-- |
|
$30.83M |
|
$52.51M |
|
|
Common Equity |
$346.18M |
$346.18M |
|
$346.18M |
|
135.94M |
|
| Cash Flow Statement Financials | |
$-138.89M |
|
$-40.87M |
|
$222.50M |
|
$72.10M |
|
$114.85M |
|
$42.75M |
|
$26.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-139.93M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-11.19% |
|
-11.19% |
|
-9.72% |
|
-11.19% |
|
$2.55 |
|
$-1.20 |
|
$-1.20 |
|